These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 7678314)

  • 1. Effect of aprotinin (Trasylol) on aorta-coronary bypass graft patency.
    Bidstrup BP; Underwood SR; Sapsford RN; Streets EM
    J Thorac Cardiovasc Surg; 1993 Jan; 105(1):147-52; discussion 153. PubMed ID: 7678314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction in blood loss and blood use after cardiopulmonary bypass with high dose aprotinin (Trasylol).
    Bidstrup BP; Royston D; Sapsford RN; Taylor KM
    J Thorac Cardiovasc Surg; 1989 Mar; 97(3):364-72. PubMed ID: 2465457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
    Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R
    Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Reduction of per- and postoperative blood loss with aprotinin (Trasylol) during extracorporeal circulation].
    Deleuze P; Loisance DY; Feliz A; Hillion ML; Castanié JB; Richemond J; Cachera JP
    Arch Mal Coeur Vaiss; 1991 Dec; 84(12):1797-802. PubMed ID: 1724365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of two different doses of aprotinin on hemostasis in cardiopulmonary bypass surgery: similar transfusion requirements and blood loss.
    Santamaría A; Mateo J; Oliver A; Litvan H; Murillo J; Souto JC; Fontcuberta J
    Haematologica; 2000 Dec; 85(12):1277-84. PubMed ID: 11114135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose postoperative aprotinin reduces mediastinal drainage and blood product use in patients undergoing primary coronary artery bypass grafting who are taking aspirin: a prospective, randomized, double-blind, placebo-controlled trial.
    Alvarez JM; Jackson LR; Chatwin C; Smolich JJ
    J Thorac Cardiovasc Surg; 2001 Sep; 122(3):457-63. PubMed ID: 11547294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of aprotinin on bleeding during and graft patency after coronary artery bypass grafting].
    Minohara S; Asada K; Kondo K; Tatsumi T; Hasegawa S; Sawada Y; Morimoto T; Matsuyama N; Sasaki S
    Nihon Kyobu Geka Gakkai Zasshi; 1997 Jun; 45(6):821-4. PubMed ID: 9217377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of aprotinin on coronary artery bypass graft patency.
    Laub GW; Riebman JB; Chen C; Adkins MS; Anderson WA; Fernandez J; McGrath LB
    Chest; 1994 Nov; 106(5):1370-5. PubMed ID: 7525162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aprotinin shows both hemostatic and antithrombotic effects during off-pump coronary artery bypass grafting.
    Poston RS; White C; Gu J; Brown J; Gammie J; Pierson RN; Lee A; Connerney I; Avari T; Christenson R; Tandry U; Griffith BP
    Ann Thorac Surg; 2006 Jan; 81(1):104-10; discussion 110-1. PubMed ID: 16368345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aprotinin does not compromise arterial graft patency in coronary bypass operations.
    Jegaden O; Vedrinne C; Rossi R
    J Thorac Cardiovasc Surg; 1993 Jul; 106(1):180-1. PubMed ID: 7686595
    [No Abstract]   [Full Text] [Related]  

  • 11. Blood loss and use of blood in internal mammary artery and saphenous vein bypass grafting with and without adding a single, low-dose of aprotinin (2 million units) to the pump prime.
    Schönberger JP; van Zundert A; Bredée JJ; Gardien M; Everts PA; Bavinck JH; Berreklouw E; Wildevuur CR
    Acta Anaesthesiol Belg; 1992; 43(3):187-96. PubMed ID: 1280395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of epsilon-aminocaproic acid and aprotinin on fibrinolysis and blood loss in patients undergoing primary, isolated coronary artery bypass surgery: a randomized, double-blind, placebo-controlled, noninferiority trial.
    Greilich PE; Jessen ME; Satyanarayana N; Whitten CW; Nuttall GA; Beckham JM; Wall MH; Butterworth JF
    Anesth Analg; 2009 Jul; 109(1):15-24. PubMed ID: 19535691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aprotinin decreases postoperative bleeding and number of transfusions in patients on clopidogrel undergoing coronary artery bypass graft surgery: a double-blind, placebo-controlled, randomized clinical trial.
    van der Linden J; Lindvall G; Sartipy U
    Circulation; 2005 Aug; 112(9 Suppl):I276-80. PubMed ID: 16159831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose aprotinin in cardiac operations.
    Haddad R; Kesrouani C; Nasr W
    J Med Liban; 2000; 48(3):157-60. PubMed ID: 11268570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radial artery versus saphenous vein patency randomized trial: five-year angiographic follow-up.
    Collins P; Webb CM; Chong CF; Moat NE;
    Circulation; 2008 Jun; 117(22):2859-64. PubMed ID: 18506009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aprotinin in elective primary bypass surgery. Graft patency and clinical efficacy.
    Lass M; Welz A; Kochs M; Mayer G; Schwandt M; Hannekum A
    Eur J Cardiothorac Surg; 1995; 9(4):206-10. PubMed ID: 7541637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aprotinin for coronary bypass operations: efficacy, safety, and influence on early saphenous vein graft patency. A multicenter, randomized, double-blind, placebo-controlled study.
    Lemmer JH; Stanford W; Bonney SL; Breen JF; Chomka EV; Eldredge WJ; Holt WW; Karp RB; Laub GW; Lipton MJ
    J Thorac Cardiovasc Surg; 1994 Feb; 107(2):543-51; discussion 551-3. PubMed ID: 7508070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrinolytic inhibitors in off-pump coronary surgery: a prospective, randomized, double-blind TAP study (tranexamic acid, aprotinin, placebo).
    Vanek T; Jares M; Fajt R; Straka Z; Jirasek K; Kolesar M; Brucek P; Maly M
    Eur J Cardiothorac Surg; 2005 Oct; 28(4):563-8. PubMed ID: 16125959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose aprotinin modulates the balance between proinflammatory and anti-inflammatory responses during coronary artery bypass graft surgery.
    Tassani P; Augustin N; Barankay A; Braun SL; Zaccaria F; Richter JA
    J Cardiothorac Vasc Anesth; 2000 Dec; 14(6):682-6. PubMed ID: 11139109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aprotinin reduces bleeding and blood product use in patients treated with clopidogrel before coronary artery bypass grafting.
    Lindvall G; Sartipy U; van der Linden J
    Ann Thorac Surg; 2005 Sep; 80(3):922-7. PubMed ID: 16122456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.